This guy cannot even handle a press conference,what can be expected out of him to manage a biopharm ? Junius is a big time loser ! What surprises me is how he still continues at the top without having to give any explanation to anyone about the pathetic state of affairs and it's effect on share price ! Why are everyone tight lipped ?
I have taken action, contacting BOD members, contacting DJ and Perry with shareholder complaints. Who else is taking action?
Large institutional shareholders are going to eventually move their money to a company/stock that's is shareholder and ROI friendly. At present/within the past 12+ months, IMGN has been a slacking laggard of a stock with weak, greedy management (with the exception of drug discovery which rocks).